Tead1	B:C1420679
regulates	O
the	O
expression	O
of	O
Peripheral	O
Myelin	I:C1418677
Protein	I:C1418677
22	I:C1418677
during	O
Schwann	O
cell	I:C1817645
development	I:C1817645
.	O

Tead1	O
regulates	O
the	O
expression	B:C0017262
of	O
Peripheral	O
Myelin	I:C1418677
Protein	I:C1418677
22	I:C1418677
during	O
Schwann	O
cell	I:C1817645
development	I:C1817645
.	O

Tead1	O
regulates	O
the	O
expression	O
of	O
Peripheral	B:C1418677
Myelin	I:C1418677
Protein	I:C1418677
22	I:C1418677
during	O
Schwann	O
cell	I:C1817645
development	I:C1817645
.	O

Tead1	O
regulates	O
the	O
expression	O
of	O
Peripheral	O
Myelin	I:C1418677
Protein	I:C1418677
22	I:C1418677
during	O
Schwann	B:C1817645
cell	I:C1817645
development	I:C1817645
.	O

Schwann	B:C0036387
cells	I:C0036387
are	O
myelinating	O
glia	I:C0027836
in	O
the	O
peripheral	O
nervous	I:C0206417
system	I:C0206417
that	O
form	O
the	O
myelin	O
sheath	I:C0026973
.	O

Schwann	O
cells	I:C0036387
are	O
myelinating	B:C0027836
glia	I:C0027836
in	O
the	O
peripheral	O
nervous	I:C0206417
system	I:C0206417
that	O
form	O
the	O
myelin	O
sheath	I:C0026973
.	O

Schwann	O
cells	I:C0036387
are	O
myelinating	O
glia	I:C0027836
in	O
the	O
peripheral	B:C0206417
nervous	I:C0206417
system	I:C0206417
that	O
form	O
the	O
myelin	O
sheath	I:C0026973
.	O

Schwann	O
cells	I:C0036387
are	O
myelinating	O
glia	I:C0027836
in	O
the	O
peripheral	O
nervous	I:C0206417
system	I:C0206417
that	O
form	O
the	O
myelin	B:C0026973
sheath	I:C0026973
.	O

A	O
major	O
cause	O
of	O
peripheral	B:C0031117
neuropathy	I:C0031117
is	O
a	O
copy	O
number	I:C1511518
variant	I:C1511518
involving	O
the	O
Peripheral	O
Myelin	I:C1418677
Protein	I:C1418677
22	I:C1418677
(	I:C1418677
PMP22	I:C1418677
)	I:C1418677
gene	I:C1418677
,	O
which	O
is	O
located	O
within	O
a	O
1.4	O
-	O
Mb	O
duplication	O
on	O
chromosome	O
17	I:C0008659
associated	O
with	O
the	O
most	O
common	O
form	O
of	O
Charcot	O
-	I:C0007959
Marie	I:C0007959
-	I:C0007959
Tooth	I:C0007959
Disease	I:C0007959
(	O
CMT1A	O
)	O
.	O

A	O
major	O
cause	O
of	O
peripheral	O
neuropathy	I:C0031117
is	O
a	O
copy	B:C1511518
number	I:C1511518
variant	I:C1511518
involving	O
the	O
Peripheral	O
Myelin	I:C1418677
Protein	I:C1418677
22	I:C1418677
(	I:C1418677
PMP22	I:C1418677
)	I:C1418677
gene	I:C1418677
,	O
which	O
is	O
located	O
within	O
a	O
1.4	O
-	O
Mb	O
duplication	O
on	O
chromosome	O
17	I:C0008659
associated	O
with	O
the	O
most	O
common	O
form	O
of	O
Charcot	O
-	I:C0007959
Marie	I:C0007959
-	I:C0007959
Tooth	I:C0007959
Disease	I:C0007959
(	O
CMT1A	O
)	O
.	O

A	O
major	O
cause	O
of	O
peripheral	O
neuropathy	I:C0031117
is	O
a	O
copy	O
number	I:C1511518
variant	I:C1511518
involving	O
the	O
Peripheral	B:C1418677
Myelin	I:C1418677
Protein	I:C1418677
22	I:C1418677
(	I:C1418677
PMP22	I:C1418677
)	I:C1418677
gene	I:C1418677
,	O
which	O
is	O
located	O
within	O
a	O
1.4	O
-	O
Mb	O
duplication	O
on	O
chromosome	O
17	I:C0008659
associated	O
with	O
the	O
most	O
common	O
form	O
of	O
Charcot	O
-	I:C0007959
Marie	I:C0007959
-	I:C0007959
Tooth	I:C0007959
Disease	I:C0007959
(	O
CMT1A	O
)	O
.	O

A	O
major	O
cause	O
of	O
peripheral	O
neuropathy	I:C0031117
is	O
a	O
copy	O
number	I:C1511518
variant	I:C1511518
involving	O
the	O
Peripheral	O
Myelin	I:C1418677
Protein	I:C1418677
22	I:C1418677
(	I:C1418677
PMP22	I:C1418677
)	I:C1418677
gene	I:C1418677
,	O
which	O
is	O
located	O
within	O
a	O
1.4	O
-	O
Mb	O
duplication	B:C0017261
on	O
chromosome	O
17	I:C0008659
associated	O
with	O
the	O
most	O
common	O
form	O
of	O
Charcot	O
-	I:C0007959
Marie	I:C0007959
-	I:C0007959
Tooth	I:C0007959
Disease	I:C0007959
(	O
CMT1A	O
)	O
.	O

A	O
major	O
cause	O
of	O
peripheral	O
neuropathy	I:C0031117
is	O
a	O
copy	O
number	I:C1511518
variant	I:C1511518
involving	O
the	O
Peripheral	O
Myelin	I:C1418677
Protein	I:C1418677
22	I:C1418677
(	I:C1418677
PMP22	I:C1418677
)	I:C1418677
gene	I:C1418677
,	O
which	O
is	O
located	O
within	O
a	O
1.4	O
-	O
Mb	O
duplication	O
on	O
chromosome	B:C0008659
17	I:C0008659
associated	O
with	O
the	O
most	O
common	O
form	O
of	O
Charcot	O
-	I:C0007959
Marie	I:C0007959
-	I:C0007959
Tooth	I:C0007959
Disease	I:C0007959
(	O
CMT1A	O
)	O
.	O

A	O
major	O
cause	O
of	O
peripheral	O
neuropathy	I:C0031117
is	O
a	O
copy	O
number	I:C1511518
variant	I:C1511518
involving	O
the	O
Peripheral	O
Myelin	I:C1418677
Protein	I:C1418677
22	I:C1418677
(	I:C1418677
PMP22	I:C1418677
)	I:C1418677
gene	I:C1418677
,	O
which	O
is	O
located	O
within	O
a	O
1.4	O
-	O
Mb	O
duplication	O
on	O
chromosome	O
17	I:C0008659
associated	O
with	O
the	O
most	O
common	O
form	O
of	O
Charcot	B:C0007959
-	I:C0007959
Marie	I:C0007959
-	I:C0007959
Tooth	I:C0007959
Disease	I:C0007959
(	O
CMT1A	O
)	O
.	O

A	O
major	O
cause	O
of	O
peripheral	O
neuropathy	I:C0031117
is	O
a	O
copy	O
number	I:C1511518
variant	I:C1511518
involving	O
the	O
Peripheral	O
Myelin	I:C1418677
Protein	I:C1418677
22	I:C1418677
(	I:C1418677
PMP22	I:C1418677
)	I:C1418677
gene	I:C1418677
,	O
which	O
is	O
located	O
within	O
a	O
1.4	O
-	O
Mb	O
duplication	O
on	O
chromosome	O
17	I:C0008659
associated	O
with	O
the	O
most	O
common	O
form	O
of	O
Charcot	O
-	I:C0007959
Marie	I:C0007959
-	I:C0007959
Tooth	I:C0007959
Disease	I:C0007959
(	O
CMT1A	B:C0007959
)	O
.	O

Rodent	B:C1519106
models	I:C1519106
of	O
CMT1A	O
have	O
been	O
used	O
to	O
show	O
that	O
reducing	O
Pmp22	O
overexpression	O
mitigates	O
several	O
aspects	O
of	O
a	O
CMT1A	O
-	O
related	O
phenotype	O
.	O

Rodent	O
models	I:C1519106
of	O
CMT1A	B:C0007959
have	O
been	O
used	O
to	O
show	O
that	O
reducing	O
Pmp22	O
overexpression	O
mitigates	O
several	O
aspects	O
of	O
a	O
CMT1A	O
-	O
related	O
phenotype	O
.	O

Rodent	O
models	I:C1519106
of	O
CMT1A	O
have	O
been	O
used	O
to	O
show	O
that	O
reducing	O
Pmp22	B:C1418677
overexpression	O
mitigates	O
several	O
aspects	O
of	O
a	O
CMT1A	O
-	O
related	O
phenotype	O
.	O

Rodent	O
models	I:C1519106
of	O
CMT1A	O
have	O
been	O
used	O
to	O
show	O
that	O
reducing	O
Pmp22	O
overexpression	B:C0017262
mitigates	O
several	O
aspects	O
of	O
a	O
CMT1A	O
-	O
related	O
phenotype	O
.	O

Rodent	O
models	I:C1519106
of	O
CMT1A	O
have	O
been	O
used	O
to	O
show	O
that	O
reducing	O
Pmp22	O
overexpression	O
mitigates	O
several	O
aspects	O
of	O
a	O
CMT1A	B:C0007959
-	O
related	O
phenotype	O
.	O

Mechanistic	O
studies	B:C2603343
of	O
Pmp22	O
regulation	O
identified	O
enhancers	O
regulated	O
by	O
the	O
sex	O
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
(	O
SRY	O
sex	I:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
)	O
and	O
Egr2	O
/	O
Krox20	O
(	O
Early	O
growth	I:C0064419
response	I:C0064419
protein	I:C0064419
2	I:C0064419
)	O
transcription	O
factors	I:C0040648
in	O
myelinated	O
nerves	I:C0027750
.	O

Mechanistic	O
studies	O
of	O
Pmp22	B:C1418677
regulation	O
identified	O
enhancers	O
regulated	O
by	O
the	O
sex	O
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
(	O
SRY	O
sex	I:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
)	O
and	O
Egr2	O
/	O
Krox20	O
(	O
Early	O
growth	I:C0064419
response	I:C0064419
protein	I:C0064419
2	I:C0064419
)	O
transcription	O
factors	I:C0040648
in	O
myelinated	O
nerves	I:C0027750
.	O

Mechanistic	O
studies	O
of	O
Pmp22	O
regulation	B:C0017263
identified	O
enhancers	O
regulated	O
by	O
the	O
sex	O
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
(	O
SRY	O
sex	I:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
)	O
and	O
Egr2	O
/	O
Krox20	O
(	O
Early	O
growth	I:C0064419
response	I:C0064419
protein	I:C0064419
2	I:C0064419
)	O
transcription	O
factors	I:C0040648
in	O
myelinated	O
nerves	I:C0027750
.	O

Mechanistic	O
studies	O
of	O
Pmp22	O
regulation	O
identified	O
enhancers	B:C0014290
regulated	O
by	O
the	O
sex	O
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
(	O
SRY	O
sex	I:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
)	O
and	O
Egr2	O
/	O
Krox20	O
(	O
Early	O
growth	I:C0064419
response	I:C0064419
protein	I:C0064419
2	I:C0064419
)	O
transcription	O
factors	I:C0040648
in	O
myelinated	O
nerves	I:C0027750
.	O

Mechanistic	O
studies	O
of	O
Pmp22	O
regulation	O
identified	O
enhancers	O
regulated	O
by	O
the	O
sex	B:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
(	O
SRY	O
sex	I:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
)	O
and	O
Egr2	O
/	O
Krox20	O
(	O
Early	O
growth	I:C0064419
response	I:C0064419
protein	I:C0064419
2	I:C0064419
)	O
transcription	O
factors	I:C0040648
in	O
myelinated	O
nerves	I:C0027750
.	O

Mechanistic	O
studies	O
of	O
Pmp22	O
regulation	O
identified	O
enhancers	O
regulated	O
by	O
the	O
sex	O
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
(	O
SRY	B:C1571654
sex	I:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
)	O
and	O
Egr2	O
/	O
Krox20	O
(	O
Early	O
growth	I:C0064419
response	I:C0064419
protein	I:C0064419
2	I:C0064419
)	O
transcription	O
factors	I:C0040648
in	O
myelinated	O
nerves	I:C0027750
.	O

Mechanistic	O
studies	O
of	O
Pmp22	O
regulation	O
identified	O
enhancers	O
regulated	O
by	O
the	O
sex	O
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
(	O
SRY	O
sex	I:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
)	O
and	O
Egr2	B:C0064419
/	O
Krox20	O
(	O
Early	O
growth	I:C0064419
response	I:C0064419
protein	I:C0064419
2	I:C0064419
)	O
transcription	O
factors	I:C0040648
in	O
myelinated	O
nerves	I:C0027750
.	O

Mechanistic	O
studies	O
of	O
Pmp22	O
regulation	O
identified	O
enhancers	O
regulated	O
by	O
the	O
sex	O
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
(	O
SRY	O
sex	I:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
)	O
and	O
Egr2	O
/	O
Krox20	B:C0064419
(	O
Early	O
growth	I:C0064419
response	I:C0064419
protein	I:C0064419
2	I:C0064419
)	O
transcription	O
factors	I:C0040648
in	O
myelinated	O
nerves	I:C0027750
.	O

Mechanistic	O
studies	O
of	O
Pmp22	O
regulation	O
identified	O
enhancers	O
regulated	O
by	O
the	O
sex	O
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
(	O
SRY	O
sex	I:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
)	O
and	O
Egr2	O
/	O
Krox20	O
(	O
Early	B:C0064419
growth	I:C0064419
response	I:C0064419
protein	I:C0064419
2	I:C0064419
)	O
transcription	O
factors	I:C0040648
in	O
myelinated	O
nerves	I:C0027750
.	O

Mechanistic	O
studies	O
of	O
Pmp22	O
regulation	O
identified	O
enhancers	O
regulated	O
by	O
the	O
sex	O
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
(	O
SRY	O
sex	I:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
)	O
and	O
Egr2	O
/	O
Krox20	O
(	O
Early	O
growth	I:C0064419
response	I:C0064419
protein	I:C0064419
2	I:C0064419
)	O
transcription	B:C0040648
factors	I:C0040648
in	O
myelinated	O
nerves	I:C0027750
.	O

Mechanistic	O
studies	O
of	O
Pmp22	O
regulation	O
identified	O
enhancers	O
regulated	O
by	O
the	O
sex	O
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
(	O
SRY	O
sex	I:C1571654
determining	I:C1571654
region	I:C1571654
Y	I:C1571654
-	I:C1571654
box	I:C1571654
10	I:C1571654
)	O
and	O
Egr2	O
/	O
Krox20	O
(	O
Early	O
growth	I:C0064419
response	I:C0064419
protein	I:C0064419
2	I:C0064419
)	O
transcription	O
factors	I:C0040648
in	O
myelinated	B:C0027750
nerves	I:C0027750
.	O

However	O
,	O
relatively	O
little	O
is	O
known	O
regarding	O
how	O
other	O
transcription	B:C0040648
factors	I:C0040648
induce	O
Pmp22	O
expression	O
during	O
Schwann	O
cell	I:C1817645
development	I:C1817645
and	O
myelination	O
.	O

However	O
,	O
relatively	O
little	O
is	O
known	O
regarding	O
how	O
other	O
transcription	O
factors	I:C0040648
induce	O
Pmp22	B:C1418677
expression	O
during	O
Schwann	O
cell	I:C1817645
development	I:C1817645
and	O
myelination	O
.	O

However	O
,	O
relatively	O
little	O
is	O
known	O
regarding	O
how	O
other	O
transcription	O
factors	I:C0040648
induce	O
Pmp22	O
expression	B:C0017262
during	O
Schwann	O
cell	I:C1817645
development	I:C1817645
and	O
myelination	O
.	O

However	O
,	O
relatively	O
little	O
is	O
known	O
regarding	O
how	O
other	O
transcription	O
factors	I:C0040648
induce	O
Pmp22	O
expression	O
during	O
Schwann	B:C1817645
cell	I:C1817645
development	I:C1817645
and	O
myelination	O
.	O

However	O
,	O
relatively	O
little	O
is	O
known	O
regarding	O
how	O
other	O
transcription	O
factors	I:C0040648
induce	O
Pmp22	O
expression	O
during	O
Schwann	O
cell	I:C1817645
development	I:C1817645
and	O
myelination	B:C0596991
.	O

Here	O
,	O
we	O
examined	O
Pmp22	B:C1418677
enhancers	O
as	O
a	O
function	O
of	O
cell	O
type	I:C1148560
-	I:C1148560
specificity	I:C1148560
,	O
nerve	O
injury	I:C0161479
and	O
development	O
.	O

Here	O
,	O
we	O
examined	O
Pmp22	O
enhancers	B:C0014290
as	O
a	O
function	O
of	O
cell	O
type	I:C1148560
-	I:C1148560
specificity	I:C1148560
,	O
nerve	O
injury	I:C0161479
and	O
development	O
.	O

Here	O
,	O
we	O
examined	O
Pmp22	O
enhancers	O
as	O
a	O
function	O
of	O
cell	B:C1148560
type	I:C1148560
-	I:C1148560
specificity	I:C1148560
,	O
nerve	O
injury	I:C0161479
and	O
development	O
.	O

Here	O
,	O
we	O
examined	O
Pmp22	O
enhancers	O
as	O
a	O
function	O
of	O
cell	O
type	I:C1148560
-	I:C1148560
specificity	I:C1148560
,	O
nerve	B:C0161479
injury	I:C0161479
and	O
development	O
.	O

While	O
Pmp22	B:C1418677
enhancers	O
marked	O
by	O
active	O
histone	O
modifications	I:C1156199
were	O
lost	O
or	O
remodeled	O
after	O
injury	O
,	O
we	O
found	O
that	O
these	O
enhancers	O
were	O
permissive	O
in	O
early	O
development	O
prior	O
to	O
Pmp22	O
upregulation	O
.	O

While	O
Pmp22	O
enhancers	B:C0014290
marked	O
by	O
active	O
histone	O
modifications	I:C1156199
were	O
lost	O
or	O
remodeled	O
after	O
injury	O
,	O
we	O
found	O
that	O
these	O
enhancers	O
were	O
permissive	O
in	O
early	O
development	O
prior	O
to	O
Pmp22	O
upregulation	O
.	O

While	O
Pmp22	O
enhancers	O
marked	O
by	O
active	O
histone	B:C1156199
modifications	I:C1156199
were	O
lost	O
or	O
remodeled	O
after	O
injury	O
,	O
we	O
found	O
that	O
these	O
enhancers	O
were	O
permissive	O
in	O
early	O
development	O
prior	O
to	O
Pmp22	O
upregulation	O
.	O

While	O
Pmp22	O
enhancers	O
marked	O
by	O
active	O
histone	O
modifications	I:C1156199
were	O
lost	O
or	O
remodeled	O
after	O
injury	B:C3263723
,	O
we	O
found	O
that	O
these	O
enhancers	O
were	O
permissive	O
in	O
early	O
development	O
prior	O
to	O
Pmp22	O
upregulation	O
.	O

While	O
Pmp22	O
enhancers	O
marked	O
by	O
active	O
histone	O
modifications	I:C1156199
were	O
lost	O
or	O
remodeled	O
after	O
injury	O
,	O
we	O
found	O
that	O
these	O
enhancers	B:C0014290
were	O
permissive	O
in	O
early	O
development	O
prior	O
to	O
Pmp22	O
upregulation	O
.	O

While	O
Pmp22	O
enhancers	O
marked	O
by	O
active	O
histone	O
modifications	I:C1156199
were	O
lost	O
or	O
remodeled	O
after	O
injury	O
,	O
we	O
found	O
that	O
these	O
enhancers	O
were	O
permissive	O
in	O
early	O
development	O
prior	O
to	O
Pmp22	B:C1418677
upregulation	O
.	O

While	O
Pmp22	O
enhancers	O
marked	O
by	O
active	O
histone	O
modifications	I:C1156199
were	O
lost	O
or	O
remodeled	O
after	O
injury	O
,	O
we	O
found	O
that	O
these	O
enhancers	O
were	O
permissive	O
in	O
early	O
development	O
prior	O
to	O
Pmp22	O
upregulation	B:C0041904
.	O

Pmp22	B:C1418677
enhancers	O
contain	O
binding	O
motifs	I:C1956035
for	O
TEA	O
domain	I:C0220134
(	O
TEA	O
domain	I:C0220134
)	O
transcription	O
factors	I:C0040648
of	O
the	O
Hippo	O
signaling	I:C3158583
pathway	I:C3158583
.	O

Pmp22	O
enhancers	B:C0014290
contain	O
binding	O
motifs	I:C1956035
for	O
TEA	O
domain	I:C0220134
(	O
TEA	O
domain	I:C0220134
)	O
transcription	O
factors	I:C0040648
of	O
the	O
Hippo	O
signaling	I:C3158583
pathway	I:C3158583
.	O

Pmp22	O
enhancers	O
contain	O
binding	B:C1956035
motifs	I:C1956035
for	O
TEA	O
domain	I:C0220134
(	O
TEA	O
domain	I:C0220134
)	O
transcription	O
factors	I:C0040648
of	O
the	O
Hippo	O
signaling	I:C3158583
pathway	I:C3158583
.	O

Pmp22	O
enhancers	O
contain	O
binding	O
motifs	I:C1956035
for	O
TEA	B:C0220134
domain	I:C0220134
(	O
TEA	O
domain	I:C0220134
)	O
transcription	O
factors	I:C0040648
of	O
the	O
Hippo	O
signaling	I:C3158583
pathway	I:C3158583
.	O

Pmp22	O
enhancers	O
contain	O
binding	O
motifs	I:C1956035
for	O
TEA	O
domain	I:C0220134
(	O
TEA	B:C0220134
domain	I:C0220134
)	O
transcription	O
factors	I:C0040648
of	O
the	O
Hippo	O
signaling	I:C3158583
pathway	I:C3158583
.	O

Pmp22	O
enhancers	O
contain	O
binding	O
motifs	I:C1956035
for	O
TEA	O
domain	I:C0220134
(	O
TEA	O
domain	I:C0220134
)	O
transcription	B:C0040648
factors	I:C0040648
of	O
the	O
Hippo	O
signaling	I:C3158583
pathway	I:C3158583
.	O

Pmp22	O
enhancers	O
contain	O
binding	O
motifs	I:C1956035
for	O
TEA	O
domain	I:C0220134
(	O
TEA	O
domain	I:C0220134
)	O
transcription	O
factors	I:C0040648
of	O
the	O
Hippo	B:C3158583
signaling	I:C3158583
pathway	I:C3158583
.	O

We	O
discovered	O
that	O
Tead1	B:C1420679
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	B:C1424135
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	B:C1336578
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	B:C1418677
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	B:C0017262
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	B:C0017262
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	B:C1414315
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	B:C1420679
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	B:C1418677
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	B:C1414315
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	B:C0014290
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	B:C1420679
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	B:C1167622
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	B:C0596991
,	O
correlating	O
with	O
Pmp22	O
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	B:C1418677
expression	O
.	O

We	O
discovered	O
that	O
Tead1	O
and	O
co-activators	O
Yap	O
and	O
Taz	O
are	O
required	O
for	O
Pmp22	O
expression	O
,	O
as	O
well	O
as	O
for	O
the	O
expression	O
of	O
Egr2	O
Tead1	O
directly	O
binds	O
Pmp22	O
and	O
Egr2	O
enhancers	O
early	O
in	O
development	O
and	O
Tead1	O
binding	O
is	O
induced	O
during	O
myelination	O
,	O
correlating	O
with	O
Pmp22	O
expression	B:C0017262
.	O

The	O
data	O
identify	O
Tead1	B:C1420679
as	O
a	O
novel	O
regulator	O
of	O
Pmp22	O
expression	O
during	O
development	O
in	O
concert	O
with	O
sex	O
determining	I:C1420317
region	I:C1420317
Y	I:C1420317
-	I:C1420317
box	I:C1420317
10	I:C1420317
and	O
Egr2	O
.	O

The	O
data	O
identify	O
Tead1	O
as	O
a	O
novel	O
regulator	B:C0017362
of	O
Pmp22	O
expression	O
during	O
development	O
in	O
concert	O
with	O
sex	O
determining	I:C1420317
region	I:C1420317
Y	I:C1420317
-	I:C1420317
box	I:C1420317
10	I:C1420317
and	O
Egr2	O
.	O

The	O
data	O
identify	O
Tead1	O
as	O
a	O
novel	O
regulator	O
of	O
Pmp22	B:C1418677
expression	O
during	O
development	O
in	O
concert	O
with	O
sex	O
determining	I:C1420317
region	I:C1420317
Y	I:C1420317
-	I:C1420317
box	I:C1420317
10	I:C1420317
and	O
Egr2	O
.	O

The	O
data	O
identify	O
Tead1	O
as	O
a	O
novel	O
regulator	O
of	O
Pmp22	O
expression	B:C0017262
during	O
development	O
in	O
concert	O
with	O
sex	O
determining	I:C1420317
region	I:C1420317
Y	I:C1420317
-	I:C1420317
box	I:C1420317
10	I:C1420317
and	O
Egr2	O
.	O

The	O
data	O
identify	O
Tead1	O
as	O
a	O
novel	O
regulator	O
of	O
Pmp22	O
expression	O
during	O
development	O
in	O
concert	O
with	O
sex	B:C1420317
determining	I:C1420317
region	I:C1420317
Y	I:C1420317
-	I:C1420317
box	I:C1420317
10	I:C1420317
and	O
Egr2	O
.	O

The	O
data	O
identify	O
Tead1	O
as	O
a	O
novel	O
regulator	O
of	O
Pmp22	O
expression	O
during	O
development	O
in	O
concert	O
with	O
sex	O
determining	I:C1420317
region	I:C1420317
Y	I:C1420317
-	I:C1420317
box	I:C1420317
10	I:C1420317
and	O
Egr2	B:C1414315
.	O

